I am pleasantly surprised regarding the IV Cavatak trial getting to the podium. Technically i had my doubts that IV Cavatak would "seed" tumours well enough to make a big difference vs the large amount of virus they can inject directly into multiple melanoma tumours. If they are seeing improved efficacy in lung CA combined with a checkpoint inhibitor... that changes the game completely regarding valuation.
VLA Price at posting:
94.0¢ Sentiment: None Disclosure: Held